Science
Mechanism of Action
Paeoniflorin operates through several precise mechanisms to enhance skin health. It potently inhibits pro-inflammatory mediators such as IL-6 and TNF-α, along with NF‑κB activation, thereby calming inflammation and soothing skin discomfort. As a robust antioxidant, it neutralizes harmful free radicals, safeguarding the skin from environmental stressors like UV radiation and pollution, which in turn fortifies collagen integrity and delays photoaging. The ingredient also supports the skin's natural barrier function, promoting hydration and fortifying defenses against external irritants. Its skin-brightening effect stems from its ability to inhibit melanin production, effectively reducing the appearance of dark spots and hyperpigmentation. Furthermore, Paeoniflorin actively combats visible aging signs by reducing facial wrinkles, stimulating skin cell activity, and facilitating collagen fiber synthesis. It also provides microcirculation support to alleviate redness associated with microvascular hyperactivity and offers neuro-soothing benefits by modulating TRPV channels, which helps to mitigate burning, itching, and general discomfort.
Research
Clinical Evidence
High confidenceN/A
Key findings
- 01 A 0.5% concentration of partially purified paeoniflorin demonstrated a reduction in facial wrinkles in an eight-week human clinical trial.
- 02 Topical application of approximately 0.012% (120 µg/mL) resulted in a significant decrease in 2D and 3D melanin content in reconstructed pigmented human epidermis.
- 03 Concentrations ranging from 0.0001% to 0.1% exhibited at least 16.9% prevention effect against UV-induced DNA impairment.
- 04 Recommended usage concentrations include 0.1% to 0.5% for redness soothing and sensitive skin products, 0.2% to 1.0% for couperose and post-procedure care, and 0.2% to 0.8% for anti-aging and antioxidant formulations.
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Paeoniflorin is noted as heat-sensitive; an optimal pH range for its stability in formulations is not explicitly defined in current research.
Safety
Safety Profile
Paeoniflorin itself has not undergone a dedicated CIR safety assessment. While a draft CIR report for 'Paeonia suffruticosa-Derived Ingredients' (potentially containing paeoniflorin derivatives) was announced, it did not specify a maximum concentration for pure paeoniflorin in cosmetics. The FDA approved paeoniflorin for sale in 1998, likely for use as a drug or supplement ingredient. PubChem lists 'Irritant' as a primary hazard for paeoniflorin, specifically referring to acute oral toxicity, which does not directly translate to topical skin irritation or sensitization.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Paeoniflorin is a valuable, multi-functional ingredient demonstrating significant anti-aging, soothing, and brightening benefits across a range of effective concentrations, making it suitable for diverse targeted skincare formulations.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources